Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Business

Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soon

Indian generic drug giant Aurobindo Pharma announced on Friday that it is on the verge of pulling off a major expansion in the United States after clearing a critical regulatory hurdle.

The Hyderabad-based pharmaceutical heavyweight said that it has secured antitrust clearance from the US Federal Trade Commission (FTC) for its impending takeover of American drugmaker Lannett Company.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.